<DOC>
	<DOC>NCT00783601</DOC>
	<brief_summary>The purpose of the study is to demonstrate the benefit of MK0524 compared to placebo in patients with chronic asthma.</brief_summary>
	<brief_title>MK0524 Asthma POC Study (0524-008)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Has symptoms of chronic asthma (shortness of breath, wheezing, chest tightness, etc.) for at least 1 year Nonsmoker for at least 1 year with a smoking history of no more than 7 packyears (i.e., 1 pack per day for 7 years) Any clinically significant disease of heart, intestinal, kidney, liver, lung or uncontrolled blood pressure Any surgery within 4 weeks prior to Visit 1 Patient is intending to move or vacation for more than 5 days during the study Patient is pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Chronic Asthma</keyword>
</DOC>